Inspire Medical Systems Inc (NYSE:INSP)
$ 167.83 -6.54 (-3.75%) Market Cap: 4.99 Bil Enterprise Value: 4.57 Bil PE Ratio: 0 PB Ratio: 8.46 GF Score: 82/100

Inspire Medical Systems Inc at Wells Fargo Healthcare Conference Transcript

Sep 06, 2023 / 03:00PM GMT
Release Date Price: $240.05 (+2.45%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

All right. Well, good morning, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. It's my pleasure to host this session with the management team from Inspire. With us, we have Rick Buchholz, the CFO; Randy Ban, Chief Commercial Officer; and Ezgi Yagci, Head of Investor Relations.

The format is going to be fireside chat. If anybody has a question, please raise your hand. So Rick, Randy and Ezgi, thanks so much for being here.

Questions & Answers

Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

So let's start with, of course, GLP-1. There has been a lot of interest around that. Lilly is running the SURMOUNT-OSA study with tirzepatide in OSA patients. I think the study is expected to be completed, call it, late first quarter next year. I'd love to hear your general thoughts on the study and the potential implications for the market. I don

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot